Advertisement
Advertisement
U.S. Markets close in 2 hrs 40 mins
Advertisement
Advertisement
Advertisement
Advertisement

High Fusion Inc. (SPLIF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00890.0000 (0.00%)
As of 11:01AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0089
Open0.0072
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0089 - 0.0089
52 Week Range0.0072 - 0.1045
Volume66
Avg. Volume18,816
Market Cap591,753
Beta (5Y Monthly)1.01
PE Ratio (TTM)N/A
EPS (TTM)-0.0240
Earnings DateOct 31, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    High Fusion Announces Application for Management Cease Trade Order Is Denied

    Toronto, Ontario--(Newsfile Corp. - November 17, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces that its request for a Management Cease Trade Order ("MCTO") was denied on November 16, 2022, by the Ontario Securities Commission ("OSC").Pursuant to National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), the Company notified OSC on November 15, 2022, that it anticipated a delay in filing its financial statements for ...

  • Newsfile

    High Fusion Announces Application for Management Cease Trade Order

    Toronto, Ontario--(Newsfile Corp. - November 15, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces today that it has made an application to the Ontario Securities Commission to approve a temporary management cease trade order ("MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which, if granted, will prohibit trading in securities of the Company by its Chief Executive Officer and Chief Financial Officer so long ...

  • Newsfile

    High Fusion and Its Psychedelics Subsidiary Neural Therapeutics Enter into Arrangement Agreement

    Toronto, Ontario--(Newsfile Corp. - November 4, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that it has entered into a definitive arrangement agreement (the "Agreement") with Neural Therapeutics Inc. ("Neural") with respect to the distribution of a approximately one quarter of High Fusion's shareholdings in Neural to High Fusion shareholders ("Transaction").High Fusion CEO John Durfy commented, "This strategic spin-out of our holdings in Neural, f

Advertisement
Advertisement